跳至主要内容
临床试验/NCT02960828
NCT02960828Unknown不适用

Focal Subthreshold Laser Treatment for Macular Drusen

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2016年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
21
试验地点
1
主要终点
Change in drusen size

研究概览

简要总结

This study aims to validate the efficacy and safety of subthreshold laser photocoagulation on high-risk macular drusen in early age-related macular degeneration which has a high risk of conversion to exudative AMD.

详细描述

SAVE Study (Stop Early Age-related Macular Degeneration form Vision Loss Eternally)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Drusen in both eyes examined under fundoscopy
  • At least one of the eyes must have high-risk soft drusen
  • BCVA below ETDRS 83 letters
  • Patient with consent to participate

排除标准

  • Prior diagnosis with choroidal neovascularization
  • Exudative AMD in at least one eye
  • If the patient has only one visually effective eye (last eye)
  • Other macula or retinal diseases than age-related macular degeneration

研究组 & 干预措施

Intervention-"Device:_Laser"

Experimental
  • Subthreshold focal photocoagulation
  • Intravitreal Anti-vascular endothelial growth factor (Anti-VEGF) injection

干预措施: Subthreshold Laser Photocoagulation (Procedure)

Intervention-"Device:_Laser"

Experimental
  • Subthreshold focal photocoagulation
  • Intravitreal Anti-vascular endothelial growth factor (Anti-VEGF) injection

干预措施: intravitreal Anti-VEGF injection (Drug)

Intervention-"Device:_Laser"

Experimental
  • Subthreshold focal photocoagulation
  • Intravitreal Anti-vascular endothelial growth factor (Anti-VEGF) injection

干预措施: Subthreshold Laser (Device)

结局指标

主要结局

Change in drusen size

时间窗: 3 month interval

次要结局

  • Change in drusen distribution(3 month interval)
  • Best Corrected Visual Acuity (BCVA)(3 months interval)
  • Change in autofluorescence(3 month interval)
  • Choroidal Neovascularization(3 months interval)
  • Contrast Sensitivity(3 months interval)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kyu Hyung Park

Professor, Chief of department of Ophthalmology

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验